Characterization of


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
18 10 2023
Historique:
medline: 23 10 2023
pubmed: 11 9 2023
entrez: 11 9 2023
Statut: ppublish

Résumé

A double

Identifiants

pubmed: 37695298
doi: 10.1128/aac.00480-23
pmc: PMC10583683
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
beta-Lactamases EC 3.5.2.6
ceftolozane 37A4IES95Q
ceftolozane, tazobactam drug combination 0
Cephalosporins 0
Imipenem 71OTZ9ZE0A
Tazobactam SE10G96M8W

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0048023

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Antimicrob Agents Chemother. 1997 Apr;41(4):733-8
pubmed: 9087479
Annu Rev Microbiol. 2019 Sep 8;73:359-385
pubmed: 31500532
Antimicrob Agents Chemother. 2020 Aug 20;64(9):
pubmed: 32660987
Mol Microbiol. 1992 Nov;6(22):3385-93
pubmed: 1283002
PLoS Comput Biol. 2016 Mar 11;12(3):e1004782
pubmed: 26967893
mSystems. 2019 Dec 3;4(6):
pubmed: 31796566
J Antimicrob Chemother. 2018 Mar 1;73(3):658-663
pubmed: 29149337
Antimicrob Agents Chemother. 2023 Feb 16;67(2):e0140922
pubmed: 36715512
Int J Antimicrob Agents. 2022 Sep;60(3):106616
pubmed: 35691605
Front Pharmacol. 2021 Oct 29;12:770518
pubmed: 34776982
Antimicrob Agents Chemother. 2020 Jul 22;64(8):
pubmed: 32513802
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28674059
Proc Natl Acad Sci U S A. 2021 Aug 3;118(31):
pubmed: 34326266
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0008921
pubmed: 34060900
Antimicrob Agents Chemother. 2013 Sep;57(9):4134-8
pubmed: 23774429
EMBO J. 1994 Oct 3;13(19):4684-94
pubmed: 7925310
Antimicrob Agents Chemother. 2019 Oct 21;63(12):
pubmed: 31636072
Antimicrob Agents Chemother. 2014 Jun;58(6):3091-9
pubmed: 24637685
Antimicrob Agents Chemother. 2010 Feb;54(2):846-51
pubmed: 19933793
Antimicrob Agents Chemother. 2022 May 17;66(5):e0018922
pubmed: 35491836
BMC Microbiol. 2020 May 24;20(1):129
pubmed: 32448155
J Antimicrob Chemother. 2020 Dec 1;75(12):3491-3500
pubmed: 32780112
Antimicrob Agents Chemother. 2015 Apr;59(4):2286-98
pubmed: 25645842
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28947473
Antimicrob Agents Chemother. 2014 Oct;58(10):6024-31
pubmed: 25070105
Pharmacol Rev. 2013 Jun 26;65(3):1053-90
pubmed: 23803529
Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0206721
pubmed: 34930034
mBio. 2019 Sep 17;10(5):
pubmed: 31530672
Clin Microbiol Infect. 2021 Nov;27(11):1631-1637
pubmed: 34015532

Auteurs

Luc Deroche (L)

Université de Poitiers, PHAR2, Inserm U1070 , Poitiers, France.
CHU de Poitiers, Département des agents infectieux , Poitiers, France.
Université de Limoges, Inserm U1092 , Limoges, France.

Vincent Aranzana-Climent (V)

Université de Poitiers, PHAR2, Inserm U1070 , Poitiers, France.

Albane Rozenholc (A)

Université de Poitiers, PHAR2, Inserm U1070 , Poitiers, France.

Laure Prouvensier (L)

Université de Poitiers, PHAR2, Inserm U1070 , Poitiers, France.
CHU de Poitiers, Laboratoire de Toxicologie et de Pharmacocinétique , Poitiers, France.

Léa Darnaud (L)

Université de Poitiers, PHAR2, Inserm U1070 , Poitiers, France.

Nicolas Grégoire (N)

Université de Poitiers, PHAR2, Inserm U1070 , Poitiers, France.
CHU de Poitiers, Laboratoire de Toxicologie et de Pharmacocinétique , Poitiers, France.

Sandrine Marchand (S)

Université de Poitiers, PHAR2, Inserm U1070 , Poitiers, France.
CHU de Poitiers, Laboratoire de Toxicologie et de Pharmacocinétique , Poitiers, France.

Marie-Cécile Ploy (M-C)

Université de Limoges, Inserm U1092 , Limoges, France.
CHU de Limoges, Laboratoire de Bactériologie-Virologie-Hygiène , Limoges, France.

Bruno François (B)

Université de Limoges, Inserm U1092 , Limoges, France.
CHU Limoges, Service de Réanimation Polyvalente , Limoges, France.
Inserm CIC 1435, CHU Limoges , Limoges, France.

William Couet (W)

Université de Poitiers, PHAR2, Inserm U1070 , Poitiers, France.
CHU de Poitiers, Laboratoire de Toxicologie et de Pharmacocinétique , Poitiers, France.

Olivier Barraud (O)

Université de Limoges, Inserm U1092 , Limoges, France.
CHU de Limoges, Laboratoire de Bactériologie-Virologie-Hygiène , Limoges, France.
Inserm CIC 1435, CHU Limoges , Limoges, France.

Julien M Buyck (JM)

Université de Poitiers, PHAR2, Inserm U1070 , Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH